Cell Source Inc logo

Cell Source Inc

OTCPK:CLCS (USA)  
$ 0.43 -0.14 (-24.56%) 11:08 PM EST
At Loss
Market Cap:
$ 24.78M
Enterprise V:
$ 31.50M
Volume:
2.02K
Avg Vol (2M):
14.71K
Trade In:
Volume:
2.02K
At Loss
Avg Vol (2M):
14.71K

Business Description

Description
Cell Source Inc is a biotechnology company focused on developing cell therapy treatments focused on immunotherapy. The company is involved with the development of proprietary immune system management technology. The company's subsidiary commercializes a suite of inventions relating to certain cancer treatments. Its other products include Anti-rejection Veto Cell tolerance therapy for both matched and mismatched allogeneic bone marrow transplantations and Anti-rejection Veto Cell tolerance therapy for both matched and mismatched organ transplantation.
Name Current Vs Industry Vs History
Equity-to-Asset -71.48
Debt-to-Equity -0.52
Debt-to-EBITDA -2.32
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 28.69
9-Day RSI 35.32
14-Day RSI 40.81
6-1 Month Momentum % 71460
12-1 Month Momentum % 30.14

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.01
Quick Ratio 0.01

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -7
Shareholder Yield % -3.48
Name Current Vs Industry Vs History
ROA % -2142.1
ROIC % -37.18

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT -7.45
EV-to-EBITDA -7.45
EV-to-FCF -12.99
Earnings Yield (Greenblatt) % -13.42
FCF Yield % -10.73

Financials

CLCS's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:CLCS

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Cell Source Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -0.15
Beta -258.51
Volatility % 49878.19
14-Day RSI 40.81
14-Day ATR ($) 0.103092
20-Day SMA ($) 0.582725
12-1 Month Momentum % 30.14
52-Week Range ($) 0.0002 - 0.8401
Shares Outstanding (Mil) 43.47

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Cell Source Inc Filings

Filing Date Document Date Form
No Filing Data

Cell Source Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Cell Source Inc Frequently Asked Questions

What is Cell Source Inc(CLCS)'s stock price today?
The current price of CLCS is $0.43. The 52 week high of CLCS is $0.84 and 52 week low is $0.00.
When is next earnings date of Cell Source Inc(CLCS)?
The next earnings date of Cell Source Inc(CLCS) is .
Does Cell Source Inc(CLCS) pay dividends? If so, how much?
Cell Source Inc(CLCS) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1